Invention Grant
- Patent Title: Therapeutic agent for neurological diseases
- Patent Title (中): 神经系统疾病治疗剂
-
Application No.: US13812726Application Date: 2011-07-15
-
Publication No.: US08975411B2Publication Date: 2015-03-10
- Inventor: Joh-E Ikeda , Noriaki Hirayama , Satoshi Inoue , Kazunori Tanaka , Takuya Kanno
- Applicant: Joh-E Ikeda , Noriaki Hirayama , Satoshi Inoue , Kazunori Tanaka , Takuya Kanno
- Applicant Address: JP Tokyo JP Osaka-shi
- Assignee: Neugen Pharma Inc.,Wakunaga Pharmaceutical Co., Ltd.
- Current Assignee: Neugen Pharma Inc.,Wakunaga Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo JP Osaka-shi
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2010-169460 20100728
- International Application: PCT/JP2011/066214 WO 20110715
- International Announcement: WO2012/014699 WO 20120202
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/14 ; C07D217/00 ; C07D217/02 ; C07D233/00 ; C07D233/88
Abstract:
An object of the present invention is to provide a pharmaceutical agent useful for treating and preventing neurological disease, having satisfactory solubility and oxidative stress-mediated cell death suppressive activity as well as capable of exhibiting excellent blood-brain barrier permeability. The present invention is directed to an acylaminoimidazole derivative represented by general formula (I) or a salt thereof, and a pharmaceutical and a therapeutic or preventive agent for neurological disease containing the same, as an active ingredient.
Public/Granted literature
- US20130190363A1 THERAPEUTIC AGENT FOR NEUROLOGICAL DISEASES Public/Granted day:2013-07-25
Information query
